Document is current
Any future updates will be listed below
-
Authors
Tsai, Lester
Nguyen, Nghia H.
Ma, Christopher
Prokop, Larry J.
Sandborn, William J.
Singh, Siddharth https://orcid.org/0000-0002-2640-7269
-
Funding
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK117058, T32DK007202, P30 DK120515)
U.S. National Library of Medicine (T15LM011271)
- License Information
-
More Information
Article History
Received: 26 October 2020
Accepted: 25 July 2021
First Online: 11 August 2021
Declarations
:
: Lester Tsai: None to declare; Nghia Nguyen—None to declare; Christopher Ma—consulting fees from AbbVie, Janssen, Takeda, Pfizer, Roche, Alimentiv (formerly Robarts Clinical Trials, Inc.); speaker's fees from AbbVie, Janssen, Takeda, and Pfizer; research support from Pfizer; Larry J. Prokop—None to declare; William J. Sandborn—research grants from Abbvie, Abivax, Arena Pharmaceuticals, Boehringer Ingelheim, Celgene, Genentech, Gilead Sciences, Glaxo Smith Kline, Janssen, Lilly, Pfizer, Prometheus Biosciences, Seres Therapeutics, Shire, Takeda, Theravance Biopharma; consulting fees from Abbvie, Abivax, Admirx, Alfasigma, Alimentiv (Robarts Clinical Trials, owned by Health Academic Research Trust [HART]), Alivio Therapeutics, Allakos, Amgen, Applied Molecular Transport, Arena Pharmaceuticals, Bausch Health (Salix), Beigene, Bellatrix Pharmaceuticals, Boehringer Ingelheim, Boston Pharmaceuticals, Bristol Meyers Squibb, Celgene, Celltrion, Cellularity, Cosmo Pharmaceuticals, Escalier Biosciences, Equillium, Forbion, Genentech/Roche, Gilead Sciences, Glenmark Pharmaceuticals, Gossamer Bio, Immunic (Vital Therapies), Index Pharmaceuticals, Intact Therapeutics, Janssen, Kyverna Therapeutics, Landos Biopharma, Lilly, Oppilan Pharma, Otsuka, Pandion Therapeutics, Pfizer, Progenity, Prometheus Biosciences, Protagonists Therapeutics, Provention Bio, Reistone Biopharma, Seres Therapeutics, Shanghai Pharma Biotherapeutics, Shire, Shoreline Biosciences, Sublimity Therapeutics, Surrozen, Takeda, Theravance Biopharma, Thetis Pharmaceuticals, Tillotts Pharma, UCB, Vendata Biosciences, Ventyx Biosciences, Vimalan Biosciences, Vivelix Pharmaceuticals, Vivreon Biosciences, Zealand Pharma; and stock or stock options from Allakos, BeiGene, Gossamer Bio, Oppilan Pharma, Prometheus Biosciences, Progenity, Shoreline Biosciences, Ventyx Biosciences, Vimalan Biosciences. Spouse: Iveric Bio—consultant, stock options; Progenity—stock; Oppilan Pharma—consultant, stock options; Prometheus Biosciences—employee, stock options; Ventyx Biosciences—stock options; Vimalan Biosciences—stock options; Siddharth Singh—research grants from AbbVie, Janssen.
